United States · 
What does MBX Capital invest in?
MBX Capital invests most often at Seed and Series A (100% of the rounds on record), in sectors such as Telehealth, Mental Health and Healthtech.
MBX Capital highlights
- 01
6 rounds on record
- 02
Mostly Seed and Series A: 100% of its rounds
- 03
Sole investor in 1 rounds, median $1.2M
What they do
Filed 1 private fund offerings with the SEC, the most recent in 2025-03From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $100K – $5.0M as they say
- Stages
- SeedSeries ASeries B
- Sectors
- TelehealthMental HealthHealthtech
- Based in
- New York City, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first6 appearances
- 2025
2 rounds
- Jun
- Feb
- 2019
2 rounds
- Jun
- May
- 2017
2 rounds
- Nov
- Mar
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration4 named
GBGurdane BhutaniMANAGING PARTNER OF MBX CAPITAL II GP, LLC, THE ISSUER'S MANAGER.iFiling they signed
HPHoang PhanOfficer of the Issuer's Administrative ManageriFiling they signed
RTRichard ThomsOfficer of the Issuer's Administrative ManageriFiling they signed
ZMZeshan MuhammediMANAGING PARTNER OF MBX CAPITAL II GP, LLC, THE ISSUER'S MANAGER.iFiling they signed
We also hold 7 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$95Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- MBX Capital, LLC
- SEC number
- CRD 312079
What they claim to have backed
From their own portfolio page (on their website)
17 of 28 we have independently watched raise
AmacaTheraArineCND Life SciencesContralineCurrent SurgicalEarliFreedom BiosciencesJunction HealthJuniper GenomicsLucy GoodsMacro TrialsOpentronsThink BioscienceTidal VisionVital BioVivodyneWaypoint BioAncilia BioAtlas HealthCase45Catena BiosciencesDognosisEdenEnoda CellworksExamolFederated BiologicsPersist AIStasis
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.